STEVEN C GILMAN Insider Trading Transactions
Get free email notifications about insider trading for STEVEN C GILMAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of STEVEN C GILMAN. STEVEN C GILMAN is EVP & Chief Scientific Officer in CUBIST PHARMACEUTICALS INC ($CBST) and Senior Vice President in CUBIST PHARMACEUTICALS INC ($CBST) and SVP, Chief Scientific Officer in CUBIST PHARMACEUTICALS INC ($CBST) and in Vericel Corp ($ASTM) and Director in Vericel Corp ($ASTM) and Director in KERYX BIOPHARMACEUTICALS INC ($KERX) and Director in SCYNEXIS INC ($SCYX) and Director in MOMENTA PHARMACEUTICALS INC ($MNTA) and CEO in CONTRAFECT Corp ($CFRX) and in Akebia Therapeutics, Inc. ($AKBA) and Director in Akebia Therapeutics, Inc. ($AKBA).
Latest Insider Trading Transactions of STEVEN C GILMAN
Sentiment: All, AKBA, CFRX, CBST, KERX, MNTA, SCYX, ASTM
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 02 2014 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | EVP & Chief Scienti ... | Option Exercise | M | 18.69 | 25,000 | 467,250 | 0 | |
Jan 02 2014 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | EVP & Chief Scienti ... | Sell | S | 68.65 | 510 | 35,009 | 23,540 | 24.1 K to 23.5 K (-2.12 %) |
Jan 02 2014 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | EVP & Chief Scienti ... | Sell | S | 67.80 | 24,490 | 1,660,434 | 24,050 | 48.5 K to 24.1 K (-50.45 %) |
Jan 02 2014 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | EVP & Chief Scienti ... | Buy | M | 18.69 | 25,000 | 467,250 | 48,540 | 23.5 K to 48.5 K (+106.20 %) |
Jan 02 2014 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | EVP & Chief Scienti ... | Buy | J | 42.59 | 111 | 4,728 | 23,540 | 23.4 K to 23.5 K (+0.47 %) |
Jan 02 2014 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | EVP & Chief Scienti ... | Gift | G | 0.00 | 188 | 0 | 23,429 | 23.2 K to 23.4 K (+0.81 %) |
Jan 02 2014 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | EVP & Chief Scienti ... | Gift | G | 0.00 | 190 | 0 | 23,241 | 23.1 K to 23.2 K (+0.82 %) |
Jan 02 2014 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | EVP & Chief Scienti ... | Gift | G | 0.00 | 192 | 0 | 23,051 | 22.9 K to 23.1 K (+0.84 %) |
Jan 02 2014 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | EVP & Chief Scienti ... | Gift | G | 0.00 | 192 | 0 | 22,859 | 23.1 K to 22.9 K (-0.83 %) |
Dec 20 2013 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | EVP & Chief Scienti ... | Gift | G | 0.00 | 195 | 0 | 23,051 | 23.2 K to 23.1 K (-0.84 %) |
Dec 20 2013 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | EVP & Chief Scienti ... | Gift | G | 0.00 | 195 | 0 | 23,246 | 23.4 K to 23.2 K (-0.83 %) |
Dec 20 2013 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | EVP & Chief Scienti ... | Gift | G | 0.00 | 195 | 0 | 23,441 | 23.6 K to 23.4 K (-0.83 %) |
Jul 02 2013 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | EVP & Chief Scienti ... | Buy | J | 48.29 | 154 | 7,437 | 2,633 | 2.5 K to 2.6 K (+6.21 %) |
Jul 02 2013 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | EVP & Chief Scienti ... | Buy | J | 36.69 | 129 | 4,732 | 23,636 | 23.5 K to 23.6 K (+0.55 %) |
Jun 03 2013 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | EVP & Chief Scienti ... | Option Exercise | M | 16.76 | 15,125 | 253,495 | 16,125 | |
Jun 03 2013 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | EVP & Chief Scienti ... | Sell | S | 54.49 | 15,125 | 824,204 | 23,507 | 38.6 K to 23.5 K (-39.15 %) |
Jun 03 2013 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | EVP & Chief Scienti ... | Buy | M | 16.76 | 15,125 | 253,495 | 38,632 | 23.5 K to 38.6 K (+64.34 %) |
May 17 2013 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | EVP & Chief Scienti ... | Option Exercise | M | 0.00 | 2,500 | 0 | 0 | |
May 17 2013 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | EVP & Chief Scienti ... | Sell | S | 48.88 | 1,201 | 58,700 | 23,507 | 24.7 K to 23.5 K (-4.86 %) |
May 17 2013 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | EVP & Chief Scienti ... | Buy | M | 0.00 | 2,500 | 0 | 24,708 | 22.2 K to 24.7 K (+11.26 %) |
May 16 2013 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | EVP & Chief Scienti ... | Option Exercise | M | 0.00 | 2,500 | 0 | 2,500 | |
May 16 2013 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | EVP & Chief Scienti ... | Sell | S | 48.41 | 1,017 | 49,238 | 22,208 | 23.2 K to 22.2 K (-4.38 %) |
May 16 2013 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | EVP & Chief Scienti ... | Buy | M | 0.00 | 2,500 | 0 | 23,225 | 20.7 K to 23.2 K (+12.06 %) |
May 15 2013 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | EVP & Chief Scienti ... | Option Exercise | M | 0.00 | 3,500 | 0 | 7,000 | |
May 15 2013 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | EVP & Chief Scienti ... | Sell | S | 49.18 | 1,135 | 55,818 | 20,725 | 21.9 K to 20.7 K (-5.19 %) |
May 15 2013 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | EVP & Chief Scienti ... | Buy | M | 0.00 | 3,500 | 0 | 21,860 | 18.4 K to 21.9 K (+19.06 %) |
Apr 02 2013 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | EVP & Chief Scienti ... | Buy | J | 46.82 | 167 | 7,819 | 445 | 278 to 445 (+60.07 %) |
Feb 20 2013 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | EVP & Chief Scienti ... | Option Exercise | M | 0.00 | 3,750 | 0 | 11,250 | |
Feb 20 2013 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | EVP & Chief Scienti ... | Option Exercise | A | 0.00 | 7,812 | 0 | 7,812 | |
Feb 20 2013 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | EVP & Chief Scienti ... | Option Exercise | A | 41.60 | 47,851 | 1,990,602 | 47,851 | |
Feb 20 2013 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | EVP & Chief Scienti ... | Option Exercise | A | 0.00 | 7,812 | 0 | 7,812 | |
Feb 20 2013 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | EVP & Chief Scienti ... | Sell | S | 41.40 | 1,233 | 51,047 | 18,360 | 19.6 K to 18.4 K (-6.29 %) |
Feb 20 2013 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | EVP & Chief Scienti ... | Buy | M | 0.00 | 3,750 | 0 | 19,593 | 15.8 K to 19.6 K (+23.67 %) |
Jan 03 2013 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | EVP & Chief Scienti ... | Option Exercise | M | 18.69 | 15,000 | 280,350 | 25,000 | |
Jan 03 2013 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | EVP & Chief Scienti ... | Sell | S | 42.98 | 15,000 | 644,745 | 15,843 | 30.8 K to 15.8 K (-48.63 %) |
Jan 03 2013 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | EVP & Chief Scienti ... | Buy | M | 18.69 | 15,000 | 280,350 | 30,843 | 15.8 K to 30.8 K (+94.68 %) |
Jan 03 2013 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | EVP & Chief Scienti ... | Buy | J | 33.12 | 138 | 4,571 | 15,843 | 15.7 K to 15.8 K (+0.88 %) |
Aug 30 2012 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | EVP & Chief Scienti ... | Gift | G | 0.00 | 217 | 0 | 15,705 | 15.9 K to 15.7 K (-1.36 %) |
Aug 30 2012 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | EVP & Chief Scienti ... | Gift | G | 0.00 | 217 | 0 | 15,922 | 16.1 K to 15.9 K (-1.34 %) |
Aug 30 2012 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | EVP & Chief Scienti ... | Gift | G | 0.00 | 217 | 0 | 16,139 | 16.4 K to 16.1 K (-1.33 %) |
Jul 03 2012 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | EVP & Chief Scienti ... | Buy | J | 37.91 | 147 | 5,573 | 2,181 | 2 K to 2.2 K (+7.23 %) |
Jul 03 2012 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | EVP & Chief Scienti ... | Buy | J | 32.22 | 142 | 4,576 | 18,521 | 18.4 K to 18.5 K (+0.77 %) |
May 17 2012 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | EVP & Chief Scienti ... | Option Exercise | M | 18.69 | 20,000 | 373,800 | 40,000 | |
May 17 2012 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | EVP & Chief Scienti ... | Sell | S | 41.57 | 20,000 | 831,466 | 18,379 | 38.4 K to 18.4 K (-52.11 %) |
May 17 2012 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | EVP & Chief Scienti ... | Buy | M | 18.69 | 20,000 | 373,800 | 38,379 | 18.4 K to 38.4 K (+108.82 %) |
May 16 2012 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | EVP & Chief Scienti ... | Option Exercise | M | 0.00 | 2,500 | 0 | 2,500 | |
May 16 2012 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | EVP & Chief Scienti ... | Option Exercise | M | 0.00 | 2,500 | 0 | 5,000 | |
May 16 2012 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | EVP & Chief Scienti ... | Sell | S | 41.85 | 798 | 33,396 | 18,379 | 19.2 K to 18.4 K (-4.16 %) |
May 16 2012 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | EVP & Chief Scienti ... | Sell | S | 41.90 | 799 | 33,479 | 19,177 | 20 K to 19.2 K (-4.00 %) |
May 16 2012 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | EVP & Chief Scienti ... | Buy | M | 0.00 | 2,500 | 0 | 19,976 | 17.5 K to 20 K (+14.31 %) |
May 16 2012 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | EVP & Chief Scienti ... | Buy | M | 0.00 | 2,500 | 0 | 17,476 | 15 K to 17.5 K (+16.69 %) |
May 15 2012 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | EVP & Chief Scienti ... | Option Exercise | M | 0.00 | 3,500 | 0 | 10,500 | |
May 15 2012 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | EVP & Chief Scienti ... | Sell | S | 41.55 | 1,135 | 47,162 | 14,976 | 16.1 K to 15 K (-7.04 %) |
May 15 2012 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | EVP & Chief Scienti ... | Buy | M | 0.00 | 3,500 | 0 | 16,111 | 12.6 K to 16.1 K (+27.75 %) |
Apr 03 2012 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | EVP & Chief Scienti ... | Buy | J | 43.25 | 131 | 5,666 | 12,611 | 12.5 K to 12.6 K (+1.05 %) |
Feb 21 2012 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | EVP & Chief Scienti ... | Option Exercise | A | 0.00 | 15,000 | 0 | 15,000 | |
Feb 21 2012 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | EVP & Chief Scienti ... | Option Exercise | A | 42.09 | 75,000 | 3,156,750 | 75,000 | |
Oct 28 2011 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | EVP & Chief Scienti ... | Option Exercise | M | 16.76 | 31,250 | 523,750 | 31,250 | |
Oct 28 2011 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | EVP & Chief Scienti ... | Option Exercise | M | 18.69 | 40,000 | 747,600 | 60,000 | |
Oct 28 2011 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | EVP & Chief Scienti ... | Sell | S | 38.70 | 71,250 | 2,757,596 | 12,480 | 83.7 K to 12.5 K (-85.09 %) |
Oct 28 2011 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | EVP & Chief Scienti ... | Buy | M | 16.76 | 31,250 | 523,750 | 83,730 | 52.5 K to 83.7 K (+59.55 %) |
Oct 28 2011 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | EVP & Chief Scienti ... | Buy | M | 18.69 | 40,000 | 747,600 | 52,480 | 12.5 K to 52.5 K (+320.51 %) |
Oct 04 2011 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | EVP & Chief Scienti ... | Buy | J | 35.32 | 11 | 389 | 12,480 | 12.5 K to 12.5 K (+0.09 %) |
Jul 05 2011 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | EVP & Chief Scienti ... | Buy | J | 35.99 | 147 | 5,291 | 12,469 | 12.3 K to 12.5 K (+1.19 %) |
May 17 2011 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | EVP & Chief Scienti ... | Option Exercise | M | 0.00 | 2,500 | 0 | 5,000 | |
May 17 2011 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | EVP & Chief Scienti ... | Option Exercise | M | 0.00 | 2,500 | 0 | 7,500 | |
May 17 2011 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | EVP & Chief Scienti ... | Option Exercise | A | 0.00 | 14,000 | 0 | 14,000 | |
May 17 2011 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | EVP & Chief Scienti ... | Option Exercise | A | 34.80 | 70,000 | 2,435,650 | 70,000 | |
May 17 2011 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | EVP & Chief Scienti ... | Buy | M | 0.00 | 2,500 | 0 | 12,322 | 9.8 K to 12.3 K (+25.45 %) |
May 17 2011 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | EVP & Chief Scienti ... | Buy | M | 0.00 | 2,500 | 0 | 9,822 | 7.3 K to 9.8 K (+34.14 %) |
Apr 04 2011 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | EVP & Chief Scienti ... | Buy | J | 25.24 | 211 | 5,326 | 7,322 | 7.1 K to 7.3 K (+2.97 %) |
Jan 03 2011 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | EVP & Chief Scienti ... | Buy | J | 17.36 | 604 | 10,484 | 7,111 | 6.5 K to 7.1 K (+9.28 %) |
Oct 19 2010 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | EVP & Chief Scienti ... | Option Exercise | A | 25.23 | 50,000 | 1,261,500 | 50,000 | |
Oct 04 2010 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | EVP & Chief Scienti ... | Buy | J | 23.39 | 46 | 1,076 | 6,507 | 6.5 K to 6.5 K (+0.71 %) |
Jul 02 2010 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | SVP, Chief Scientif ... | Buy | J | 20.60 | 241 | 4,965 | 6,461 | 6.2 K to 6.5 K (+3.87 %) |
Jul 02 2010 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | SVP, Chief Scientif ... | Buy | J | 16.17 | 621 | 10,040 | 6,220 | 5.6 K to 6.2 K (+11.09 %) |
May 18 2010 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | SVP, Chief Scientif ... | Option Exercise | M | 0.00 | 2,500 | 0 | 7,500 | |
May 18 2010 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | SVP, Chief Scientif ... | Option Exercise | A | 21.56 | 60,000 | 1,293,600 | 60,000 | |
May 18 2010 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | SVP, Chief Scientif ... | Option Exercise | A | 0.00 | 10,000 | 0 | 10,000 | |
May 18 2010 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | SVP, Chief Scientif ... | Sell | S | 21.81 | 1,035 | 22,577 | 5,599 | 6.6 K to 5.6 K (-15.60 %) |
May 18 2010 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | SVP, Chief Scientif ... | Buy | M | 0.00 | 2,500 | 0 | 6,634 | 4.1 K to 6.6 K (+60.47 %) |
Apr 01 2010 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | SVP, Chief Scientif ... | Buy | J | 22.54 | 221 | 4,981 | 4,134 | 3.9 K to 4.1 K (+5.65 %) |
Jan 04 2010 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | SVP, Chief Scientif ... | Buy | J | 15.10 | 384 | 5,797 | 3,913 | 3.5 K to 3.9 K (+10.88 %) |
Oct 01 2009 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | SVP, Chief Scientif ... | Buy | J | 20.20 | 72 | 1,454 | 3,529 | 3.5 K to 3.5 K (+2.08 %) |
Jul 02 2009 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | SVP, Chief Scientif ... | Buy | J | 18.33 | 261 | 4,784 | 3,457 | 3.2 K to 3.5 K (+8.17 %) |
Jul 02 2009 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | SVP, Chief Scientif ... | Buy | J | 15.58 | 372 | 5,796 | 3,196 | 2.8 K to 3.2 K (+13.17 %) |
May 19 2009 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | SVP, Chief Scientif ... | Option Exercise | A | 0.00 | 10,000 | 0 | 10,000 | |
May 19 2009 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | SVP, Chief Scientif ... | Option Exercise | A | 16.76 | 62,500 | 1,047,500 | 62,500 | |
Apr 02 2009 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | Senior Vice Preside ... | Buy | J | 16.36 | 293 | 4,793 | 2,824 | 2.5 K to 2.8 K (+11.58 %) |
Oct 02 2008 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | Senior Vice Preside ... | Buy | J | 22.23 | 181 | 4,024 | 2,531 | 2.4 K to 2.5 K (+7.70 %) |
Jul 01 2008 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | Senior Vice Preside ... | Buy | J | 17.86 | 229 | 4,090 | 2,350 | 2.1 K to 2.4 K (+10.80 %) |
Apr 02 2008 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | Senior Vice Preside ... | Buy | J | 18.42 | 121 | 2,229 | 2,121 | 2 K to 2.1 K (+6.05 %) |
Mar 17 2008 | CBST | CUBIST PHARMACEUTI ... | GILMAN STEVEN C | Senior Vice Preside ... | Option Exercise | A | 18.69 | 100,000 | 1,869,000 | 100,000 |